Kazia Therapeutics (KZIA) Operating Expenses (2009 - 2016)

Kazia Therapeutics' (KZIA) quarterly Operating Expenses came in at -$6.6 million in Q4 2016, down 333.6% on a QoQ basis from $2.8 million in Q2 2010.

Kazia Therapeutics (KZIA) Operating Expenses (2009 - 2016) Analysis & Trends

Kazia Therapeutics (KZIA) has 3 years of Operating Expenses data on file, last reported at -$6.6 million in Q4 2016.

Quarterly Operating Expenses changed N/A year-over-year to -$6.6 million in Q4 2016, while the trailing twelve-month figure through Jun 2018 was -$6.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $10.3 million, down 49.61% from the prior year.
Operating Expenses retreated to -$6.6 million in Q4 2016, from $2.8 million in the prior quarter.
In the past five years, Operating Expenses ranged from a high of -$6.6 million in Q4 2016 to a low of -$6.6 million in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Opex (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.09 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	3.00 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	2.89 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	505.13 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.21 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	4,978.15
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	541.02 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	1.06 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	427.03 Mn
10	Kazia Therapeutics	4.22 Bn	4.22 Bn	-	-

Download Data